Homo bacteriens and a network of surprises
The question 'are you a man or a mouse?' makes more sense in the microbiological context given that the average human being is composed of 1013 eukaryotic cells but contains 1 014 prokaryotic cells [ 13, suggesting that Linnaeus should have named us Homo bacteriens. This raises a fimdamental question -why does this enormous bacterial population, composed as it is of more than 1000 bacterial species, not induce a constant inflammatory response? After all, most commensal bacteria contain peptidoglycan and many contain one of the most potent pro-inflammatory components, lipopolysaccharide (LPS).
To account for the failure of our commensal microflora to induce inflammatory pathology we propose that these bacteria produce cytokine-like molecules which induce a network of cytokine interactions that inhibit local tissue inflammatory responses to commensal bacteria. This can occur by inhibiting the release or activity of cytokines that are proinflammatory, e.g., interleukin (1L)-1, IL-8, tumour necrosis factor (TNF), etc., or by inducing cytokines that have anti-inflammatory actions, e.g., IL-Ira, IL-10, transforming growth factor (TGF)-/?,, or both. We further propose that local host factors interact with commensal bacteria controlling their growth, metabolism and virulence. These networks of prokaryotic and eukaryotic interactions control the inflammatory response to the resident microflora.
Is there any evidence to support these speculations? In recent reviews of the disparate papers on cytokineinducing components of bacteria we have established that bacteria produce a multitude of potent (and not so potent) cytokine-inducing proteins, carbohydrates and lipids [2-51. We initially viewed these molecules as virulence factors and termed them modulins (in line with the other virulence factor classes -impedins, aggressins, etc.) as they modulate cell function via the induction of cytokine synthesis. Interestingly, some of the well-known bacterial toxins turned out to have potent cytokine-inducing activity, including haemolysins [6] , Clostridium dzficile toxin B [7] and Streptococcus pneumoniae pneumolysin [8] , raising the possibility that the term 'toxin' may be a misnomer for these multifunctional proteins. The numbers and diversity of these cytokine-inducing molecules suggest that they play a more complex role than simply tickling the host's innate defence responses.
Transgenic 'knockout' mice in which the genes for IL-2 or IL-10 had been inactivated developed severe colitis [9] or enterocolitis [lo], respectively. With the IL-2 knockout, colitis was not due to .the presence of specific pathogens and animals maintained under germ-free conditions did not develop any signs or symptoms of disease. Thus colitis was a response to the normal commensal microflora of the colon. We propose that, under normal conditions, the gut commensals produce signals that induce a particular network of cytokine interactions in the various cell populations in the gut and this dampens down local inflammation, possibly by regulating the balance of Th 1 :Th2 lymphocytes locally. However, in the absence of IL-2, this network cannot be produced and an inflammatory network of cytokine interactions ensues. Furthermore, in the IL-2 knockout, feedback from the gut epithelium to the commensal bacteria may be impaired, allowing the bacteria to produce large amounts of pro-inflammatory factors.
Viruses provide the third string to our hypothetical bow. Certain double-stranded DNA viruses produce a range of proteins that neutralise the activity of proinflammatory cytokines [ 1 13 . Many of these proteins are soluble forms of cytokine receptors that can bind and inactivate IL-1, TNF, interferons or chemokines. Similarly, the cowpox virus contains a gene (crmA) coding for a protein that inhibits the activity of IL-1 /?-converting enzyme [12] (a protease that cleaves the biologically active 17-kDa protein from the 3 1 -kDa inactive precursor) and Epstein-Barr virus produces a protein, BCRF1, which is 84% identical to the antiinflammatory human cytokine -IL-10 [13] .
The 60000 genes estimated to be in the human nucleus are but a fraction of the genes that exist in the 'bacterial genome'. Thus, based on the viral data, bacteria may produce a wide range of cytokine-like proteins with some having cytokine-modulating actions. Reports of such proteins have begun to appear recently. Perhaps the most interesting is a protein expressed by enteropathogenic strains of Escherichia coli that can inhibit the transcription of the genes for certain lymphokines, most notably IL-2, causing gut pathology similar to that seen in the IL-2 knockout mouse [ 141. The fascinating oral bacterium Actinobacillus actinomycetemcomitans [ 151 produces: (i) an 8-kDa anti-proliferative protein [ 161; (ii) a 14-kDa immunosuppressive protein that inhibits transcription of IL-2, IL-4, IL-5 and y-interferon [17] ; and (iii) a 2-kDa peptide that directly induces transcription of IL-6, a unique mechanism, as all other IL-6 inducers work at second hand via the production of IL-1 or TNF [ 181. Yersinia enterocolitica contains a gene, yopB, encoding a 4 1 -kDa protein that specifically inhibits monocyte TNF production but not that of IL-1 or IL-6 [19] . Bacterial proteinases may also play a role in modulating cytokine networks by activating [20] or inactivating [2 11 particular cytokines.
Local host factors may conversely affect bacteria providing a two-way flow of information between the prokaryotic and eukaryotic populations constituting Homo bacteriens. A growing number of host proteins, including IL-1, IL-2, IL-6, TGF-P,, insulin, and other less-defined proteins, stimulate growth of certain bacteria [4, 22] ; numerous host defence peptides, variously termed cecropins, defensins, tachyplesins and magainins [23] , may also play a role in host control of commensal bacterial growth and function.
The first bacterial cytokine network-modulating molecules are being discovered as we write. We need an appropriate terminology for these molecules. They cannot be called modulins as they are not virulence factors and the term bacteriokine springs to mind to describe these cytokine-like molecules. Given that viruses also produce these molecules, a more appropriate global term may be microkines. Whatever the name chosen, the search is now on for the molecules that produce the interacting networks which we envisage allow us to live in harmony with our commensal microflora. 
